All In MedTech

Device Trial Radar · NCT06540716

Inspire Singapore Study

Inspire Singapore Study: Confirmation of Therapy Performance

Last checked: Nov 20, 2026Latest source record: May 22, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

44

Actual

Start

Jul 25, 2024

Primary completion

Jul 17, 2025

Study completion Dec 1, 2025

Sponsor

Lead sponsor
Inspire Medical Systems, Inc.Public (INSP)
Sponsor type
Industry
First posted
Aug 6, 2024

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 21 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Prospective, multicenter, open-label study designed to confirm device performance of Inspire system in Singapore.

Conditions

  • Obstructive Sleep Apnea
  • OSA
  • Sleep Apnea

Interventions

  • Inspire SystemDevice

    Hypoglossal nerve stimulation therapy will be activated at approximately 1 month post-implant.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Inspiratory OverlapTime frame: 0-3 months post-therapy activation

Locations

2 sites in 1 country. Site status is shown where the registry gives one.

  • National University Hospital

    Singapore, Singapore

  • Singapore General Hospital

    Singapore, Singapore

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.